Researchers at the National Institutes of Health have developed a prototype device that could potentially diagnose pregnancy complications by monitoring the oxygen level of the placenta.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Science Update: Preterm birth risk increased among pregnant women at time of Kennedy assassination, according to NIH study
Women in the first trimester of pregnancy when President John F. Kennedy was assassinated in 1963 were more likely to deliver preterm compared to women who gave birth before the assassination, according to an analysis by NIH-funded researchers. The findings suggest that experiencing a sudden stress early in pregnancy may increase the risk of adverse birth outcomes.
Media Advisory: Healthy diet before and during pregnancy linked to lower risk of complications, NIH study suggests
A healthy diet around the time of conception through the second trimester may reduce the risk of several common pregnancy complications, suggests a study by researchers at the National Institutes of Health.
Media Advisory: Higher dose of DHA associated with lower early preterm birth rate, NIH-funded study finds
Women assigned to 1,000 mg of an omega-3 fatty acid, docosahexaenoic acid (DHA), daily in the last half of pregnancy had a lower rate of early preterm birth (<34 weeks gestation) than women who took the standard dose of 200 mg, found in many prenatal supplements, according to a study funded by the National Institutes of Health. Women who entered the study with low baseline DHA levels had the greatest reduction in early preterm birth.
Release: Eating habits change only slightly after gestational diabetes diagnosis, NIH study suggests
Pregnant women made only modest dietary changes after being diagnosed with gestational diabetes, according to a study by NICHD researchers.
Director's Corner: A Mother’s Day Message: Time for Action to Improve Maternal Health
NICHD Director Dr. Diana Bianchi is joined by NIH Office of Research on Women’s Health Director Dr. Janine Clayton in assessing the growing maternal health crisis in the United States and describing NIH’s efforts to address it.
Science Update: NIH-funded study raises possibility that outermost placental cells may halt spread of SARS-CoV-2
Trophoblasts—the outermost fetal cells of the placenta—may be able to contain SARS-CoV-2 and prevent it from spreading to the fetus even though these cells appear to be susceptible to infection by the virus, a study by NIH-funded researchers suggests. Further research into how trophoblasts might contain the virus could lead to ways to prevent COVID-19 in children and adults. The findings may also lead to insights on why fetuses are only rarely infected with SARS-CoV-2.
Media Advisory: New ultrasound technique detects fetal circulation problems in placenta
A team of researchers funded by the National Institutes of Health has developed a new ultrasound technique to monitor the placenta for impaired fetal blood flow early in pregnancy. The technique, which uses conventional ultrasound equipment, relies on subtle differences in the pulsation of fetal blood through the arteries at the fetal and placental ends of the umbilical cord, potentially enabling physicians to identify placental abnormalities that impair fetal blood flow and, if necessary, deliver the fetus early.
Release: Most differences in DNA binding compounds found at birth in children conceived by IVF not seen in early childhood, NIH study finds
Results bolster previous studies finding no growth, development differences with IVF.
Director's Corner: One Year of Rapid Acceleration of Diagnostics, and Anticipating New Challenges
Looking back and looking ahead. NICHD Director Dr. Diana W. Bianchi joins other leaders across NIH in reflecting on the work of the Rapid Acceleration of Diagnostics (RADx) program and discussing plans for the future.
Science Update: COVID vaccines in pregnancy boost maternal and newborn immunity, NIH-funded study suggests
Current vaccines to prevent COVID-19 are highly effective in producing antibodies in pregnant people, resulting in more antibodies than what is generated from a natural SARS-CoV-2 virus infection, according to a study funded by the National Institutes of Health. Moreover, antibodies produced after vaccination are present in breastmilk and travel across the placenta, indicating that vaccination during pregnancy will also confer immunity to newborns.
Release: Moderate daily caffeine intake during pregnancy may lead to smaller birth size
Pregnant women who consumed the caffeine equivalent of as little as half a cup of coffee a day on average had slightly smaller babies than pregnant women who did not consume caffeinated beverages, according to a study by researchers at the National Institutes of Health.
Director's Corner: Advancing Research to Understand, Treat, and Prevent Long COVID
For many COVID-19 patients, full recovery remains elusive even long after they should feel “better.” NIH recently announced research opportunities to understand COVID-19 long haulers, who have what researchers now refer to as Post-acute sequelae of SARS-CoV-2 infection (PASC). NICHD joins these opportunities while remaining focused on PASC patients within our audiences of interest—pregnant and lactating people, children, and those with disabilities.
Science Update: Eviction during pregnancy linked to earlier births, reduced birthweight, according to NICHD-funded study
Women facing eviction from their homes while they were pregnant are more likely to have poor birth outcomes, compared to women who faced eviction before or after they were pregnant, according to a study funded in part by NICHD.
Release: NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who have been prescribed the drug to treat COVID-19. The study, which will be conducted at 17 sites in the continental United States and Puerto Rico, aims to determine how pregnant women metabolize the drug and whether there are any potential side effects.
Media Advisory: NIH calls for greater inclusion of pregnant and lactating people in COVID-19 vaccine research
Pregnant people need to be protected through research rather than from research, the authors contend.
Director's Corner: Including pregnant and lactating people in SARS-CoV-2 vaccine research
As the COVID-19 pandemic persists, SARS-CoV-2 vaccines offer the potential to halt the spread of the virus. Yet, we know very little about the effectiveness and safety of the vaccines during pregnancy.
Media Advisory: Severe COVID-19 in pregnancy associated with preterm birth, other complications
NIH-funded study suggests mother-to-infant transmission appears to be rare
Media Advisory: Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
Contrary to previous findings, low-dose aspirin therapy before conception and during early pregnancy may increase pregnancy chances and live births among women who have experienced one or two prior miscarriages, suggests a study by researchers at the National Institutes of Health. Rather than looking solely at the difference in pregnancy rates between women who were given aspirin and those receiving a placebo, the study also accounted for differences in total aspirin use between women who deviated from the daily regimen and those who adhered to it.
Science Update: Childbirth during COVID-19 pandemic associated with anxiety, post-traumatic stress symptoms, NIH-supported study suggests
Increased stress may interfere with adjustment to new motherhood, mother-infant bonding